LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

Home・Akciju saraksts・Treace Medical Concepts Inc

Treace Medical Concepts Inc

Slēgts

7.7 6.21

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

6.74

Max

7.77

Galvenie mērījumi
By Trading Economics
Ienākumi	-1.5M -17M
Pārdošana	-5.2M 47M
Peļņas marža	-36.715
Darbinieki	477
EBITDA	-1.4M -14M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+21.85% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2025. g. 4. nov.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	92M 445M
Iepriekšējā atvēršanas cena	1.49
Iepriekšējā slēgšanas cena	7.7

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

7.16 / 7.65 Atbalsts un pretestība

Treace Medical Concepts Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 22. aug. 23:09 UTC

Iegādes, apvienošanās, pārņemšana

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 4th Update

2025. g. 22. aug. 22:02 UTC

Iegādes, apvienošanās, pārņemšana

Agreement Could Also Lead to Deeper Collaboration Between CSX, BNSF

2025. g. 22. aug. 22:02 UTC

Iegādes, apvienošanās, pārņemšana

Some Analysts Say Agreement Suggests Lack of Confidence in Merger

2025. g. 22. aug. 22:02 UTC

Iegādes, apvienošanās, pārņemšana

CSX, BNSF Intermodal Pact Draws Competing Views on Merger Possibility

2025. g. 22. aug. 22:02 UTC

Iegādes, apvienošanās, pārņemšana

CSX, BNSF Pact Sparks Debate on Whether Another Rail Merger Is Approaching -- Analysis

2025. g. 22. aug. 22:02 UTC

Iegādes, apvienošanās, pārņemšana

Pact Could Show Regulators That Transcontinental Service Can Come Without Merger

2025. g. 22. aug. 21:23 UTC

Tirgus saruna

Moody's Lowers Outlook on Austria to Negative From Stable -- Market Talk

2025. g. 22. aug. 21:18 UTC

Tirgus saruna

US Economic Growth Seen Slowing This Year -- Market Talk

2025. g. 22. aug. 21:18 UTC

Iegādes, apvienošanās, pārņemšana

U.S. Takes 10% Stake in Intel -- Barrons.com

2025. g. 22. aug. 21:03 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 22. aug. 21:03 UTC

Tirgus saruna

Mexican Stocks Close At Record High -- Market Talk

2025. g. 22. aug. 20:58 UTC

Tirgus saruna

US General Government Deficit Expected to Rise in 2026, 2027 -- Market Talk

2025. g. 22. aug. 20:57 UTC

Iegādes, apvienošanās, pārņemšana

Intel: Government's Investment in Intel Will Be a Passive Ownership, With No Bd Representation or Other Governance or Info Rights >INTC

2025. g. 22. aug. 20:57 UTC

Iegādes, apvienošanās, pārņemšana

Intel: Government Also Agrees to Vote With the Company's Bd of Directors on Matters Requiring Shareholder Approval, With Limited Exceptions >INTC

2025. g. 22. aug. 20:57 UTC

Iegādes, apvienošanās, pārņemšana

Intel: Government Equity Stake Will Be Funded by Remaining $5.7B in Grants Previously Awarded, But Not Yet Paid, Under U.S. CHIPS and Science Act and $3.2B Awarded as Part of Secure Enclave Program >INTC

2025. g. 22. aug. 20:57 UTC

Iegādes, apvienošanās, pārņemšana

Intel: Government Agrees to Purchase 433.3M Primary Shrs of Intel Common Stk at a Price of $20.47 per Shr, Equivalent to a 9.9% Stake in Co >INTC

2025. g. 22. aug. 20:57 UTC

Iegādes, apvienošanās, pārņemšana

Intel: U.S. Government to Make $8.9B Investment in Intel Common Stk as Co Builds Upon Its More Than $100B Expansion of Resilient Semiconductor Supply Chain >INTC

2025. g. 22. aug. 20:57 UTC

Iegādes, apvienošanās, pārņemšana

Intel: Intel and Trump Admin Reach Historic Agreement to Accelerate Amer Technology and Manufacturing Leadership

2025. g. 22. aug. 20:56 UTC

Peļņas

These Stocks Moved the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

2025. g. 22. aug. 20:55 UTC

Peļņas

These Stocks Are Moving the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

2025. g. 22. aug. 20:50 UTC

Tirgus saruna

Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 22. aug. 20:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Basic Materials Roundup: Market Talk

2025. g. 22. aug. 20:41 UTC

Iegādes, apvienošanās, pārņemšana

U.S. Has 10% Stake in Intel, Lutnick Says -- Barrons.com

2025. g. 22. aug. 20:24 UTC

Iegādes, apvienošanās, pārņemšana

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 3rd Update

2025. g. 22. aug. 20:16 UTC

Iegādes, apvienošanās, pārņemšana

CSX and Warren Buffett's BNSF Made News. Why Investors Are Disappointed. -- Barrons.com

2025. g. 22. aug. 19:19 UTC

Tirgus saruna

Boeing to Restart Talks With Defense Workers' Union Monday -- Market Talk

2025. g. 22. aug. 19:10 UTC

Tirgus saruna

Oil Futures Gain as Russia-Ukraine Peace Seems Distant -- Market Talk

2025. g. 22. aug. 19:06 UTC

Tirgus saruna

U.S. Natural Gas Extends Losses as Summer Nears an End -- Market Talk

2025. g. 22. aug. 19:03 UTC

Tirgus saruna

Lower Borrowing Rates Elusive Even if Fed Cuts -- Market Talk

2025. g. 22. aug. 18:52 UTC

Iegādes, apvienošanās, pārņemšana

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 2nd Update

Salīdzinājums

Cenas izmaiņa

Treace Medical Concepts Inc Prognoze

Cenas mērķis

By TipRanks

21.85% augšup

Prognoze 12 mēnešiem

Vidējais 8.7 USD 21.85%

Augstākais 12 USD

Zemākais 6 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Treace Medical Concepts Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

6 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 6 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Treace Medical Concepts Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

7.16 / 7.65Atbalsts un pretestība

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

There is one bullish event.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.